Onstryv Now Available to Patients with Parkinson’s Disease in Canada

Onstryv Now Available to Patients with Parkinson’s Disease in Canada
Patients in Canada with diagnosed Parkinson’s disease can now receive Onstryv (safinamide) to help manage their symptoms and their “off” episodes. This follows the approval of Onstryv by Health Canada in January 2019 as an add-on treatment to improve motor function in Parkinson’s patients who experience “off periods” while taking other therapies such as levodopa. The oral therapy will be ... read more
Source: Parkinson’s News TodayPublished on 2019-07-12By Alice Melão